Xoma Corporation

Xoma Corporation is a biotechnology company that focuses on the discovery, development, and manufacture of therapeutic monoclonal antibodies. The primary function of Xoma is to leverage its expertise in antibody research to develop a portfolio of innovative drugs that target a wide range of diseases. Key characteristics of Xoma's operations include their proprietary platform for creating allosteric modulating antibodies, which allow for precise targeting of cellular pathways that have the potential to treat complex and chronic conditions such as cancer, autoimmune disorders, and infectious diseases. The company plays a significant role in the biotechnology industry as it collaborates with other pharmaceutical companies to co-develop these therapies, which can lead to new treatment options and advancements in healthcare. Xoma's focus on licensing its technologies and securing revenue-generating agreements positions it as a notable player in the biotech sector, providing both therapeutic advancements and financial partnerships.